According to a new report, published by KBV research, The Global Viscosupplementation Market size is expected to reach $8.2 billion by 2030, rising at a market growth of 8.6% CAGR during the forecast period.
The Hand Osteoarthritis segment is registering a CAGR of 8.9% during (2023 - 2030). The National Library of Medicine defines hand osteoarthritis (OA) as a painful disorder that progresses over time and has a high clinical burden. The prevalence of hand OA varies by country, from 21% in the US to 92% in Japan, according to radiological studies. Similar disparities exist in the prevalence of symptomatic hand OA, which affects anywhere from 3% of people in Iran and China to 16% of people in the United States.
The Three Injection segment is leading the Global Viscosupplementation Market by Product in 2022: thereby, achieving a market value of $3.6 billion by 2030. Due to their effectiveness, three injectable treatments are the most popular treatment for osteoarthritis. In cases of osteoarthritis, physicians typically favor three injections to avoid total knee replacement surgery. The availability of various three-injection treatments further aids the segment’ expansion.
The Hospitals segment would obtain a CAGR of 8% during (2023 - 2030). During the projection period, the hospital segment is anticipated to maintain this trend due to increased hospitals and government spending on the construction of healthcare infrastructure. Hospitals have access to a diverse team of medical professionals, including orthopedic surgeons, rheumatologists, and pain management specialists.
The Asia Pacific region dominated the Global Viscosupplementation Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $3.1 billion by 2030. The North America market is poised to grow at a CAGR of 8.2% during (2023 - 2030). Additionally, The Europe market would witness a CAGR of 8.4% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/viscosupplementation-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of DePuy Synthes (Johnson & Johnson), Sanofi S.A., Zimmer Biomet Holdings, Inc., Ferring Holdings SA, F. Hoffmann-La Roche Ltd., LG Chem Ltd. (LG Corporation), Anika Therapeutics, Inc., Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A), Smith & Nephew PLC and Seikagaku Corp.
By Application
By Product
By End-use
By Geography
Companies Profiled
Unique Offerings 
